Evidence map›Paper›PMID 33525909›Full record

ArticleJournal of the American Heart Association2021

SiglecF(HI) Marks Late-Stage Neutrophils of the Infarcted Heart: A Single-Cell Transcriptomic Analysis of Neutrophil Diversification.

David M Calcagno, Claire Zhang, Avinash Toomu, Kenneth Huang, Van K Ninh, Shigeki Miyamoto, Aaron D Aguirre, Zhenxing Fu, Joan Heller Brown, Kevin R King

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Neutrophils in Myocardial Infarction.JACC. Basic to translational science · 2025
    Article
  17. Review
  18. Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David M CalcagnoDepartment of Bioengineering Jacobs School of Engineering University of California San Diego La Jolla CA.
Claire ZhangDepartment of Bioengineering Jacobs School of Engineering University of California San Diego La Jolla CA.
Avinash ToomuDepartment of Bioengineering Jacobs School of Engineering University of California San Diego La Jolla CA.
Kenneth HuangDivision of Cardiology and Cardiovascular Institute Department of Medicine University of California San Diego La Jolla CA.
Van K NinhDepartment of Pharmacology University of California San Diego La Jolla CA.
Shigeki MiyamotoDepartment of Pharmacology University of California San Diego La Jolla CA.
Aaron D AguirreCardiology Division Center for Systems Biology Wellman Center for Photomedicine Massachusetts General Hospital Boston MA.
Zhenxing FuDivision of Cardiology and Cardiovascular Institute Department of Medicine University of California San Diego La Jolla CA.
Joan Heller BrownDepartment of Pharmacology University of California San Diego La Jolla CA.
Kevin R KingDepartment of Bioengineering Jacobs School of Engineering University of California San Diego La Jolla CA.

Funding

Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
Integrative Bioengineering of Heart, Vessels, and BloodT32HL105373 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, INTAGLIETTA, MARCOS · 2010 to 2019
$3.6M
Elucidating Cell Communication Networks during Tissue Inflammation, Fibrosis, and RegenerationDP2AR075321 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KING, KEVIN R · 2018 to 2018
$2.4M
Cardiomyocyte CaM kinase II as a driver of cardiac inflammation and remodelingR01HL145459 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, MIYAMOTO, SHIGEKI · 2019 to 2022
$1.6M
Danger Signaling and Spread of Injury after Myocardial InfarctionR00HL129168 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KING, KEVIN R · 2017 to 2019
$746k
Danger Signaling and Spread of Injury after Myocardial InfarctionK99HL129168 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KING, KEVIN R · 2015 to 2016
$309k
NHLBI NIH HHS K99 HL129168NHLBI NIH HHS R00 HL129168NHLBI NIH HHS R01 HL145459NHLBI NIH HHS T32 HL007444NHLBI NIH HHS T32 HL105373NIAMS NIH HHS DP2 AR075321
6 · The paper itself

Abstract

Background Neutrophils are thought to be short-lived first responders to tissue injuries such as myocardial infarction (MI), but little is known about their diversification or dynamics. Methods and Results We permanently ligated the left anterior descending coronary arteries of mice and performed single-cell RNA sequencing and analysis of >28 000 neutrophil transcriptomes isolated from the heart, peripheral blood, and bone marrow of mice on days 1 to 4 after MI or at steady-state. Unsupervised clustering of cardiac neutrophils revealed 5 major subsets, 3 of which originated in the bone marrow, including a late-emerging granulocyte expressing SiglecF, a marker classically used to define eosinophils. SiglecF

Indexed as

TranscriptomeAnimalsDisease Models, AnimalMiceMice, Inbred C57BLMyocardial InfarctionMyocardiumNeutrophilsSequence Analysis, RNASialic Acid Binding Immunoglobulin-like LectinsSingle-Cell AnalysisSialic Acid Binding Immunoglobulin-like LectinsSiglecf protein, mousegranulopoiesisheartmyocardial infarctionneutrophil maturityneutrophilssiglecFsingle‐cell RNA sequencing

Identifiers

PMID33525909
PMCPMC7955351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.